Comparison of muscle relaxant dose of cis-atracurium based on body fat mass (FFM), total body weight (TBW) and ideal body weight (IBW) in patients undergoing obesity surgery.
Phase 3
Recruiting
- Conditions
- Obesity.Overweight and obesity
- Registration Number
- IRCT20151107024909N9
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Ages 18 to 60
Patients with physical level below 3 according to the American Society of Anesthesiologists classification
BMI greater than ²35 kg / m
Normal kidney and liver function confirmed by routine screening tests
Exclusion Criteria
Pregnancy ,
Neuromuscular Disease
Treatment with Well-known Interventions in Muscle Neurotransmission
Psychological Disorder
Allergy to Cis-atracurium
Criteria for Difficult Intubation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of muscle relaxation. Timepoint: During surgery. Method of measurement: Minutes.;Dose of Cisatracurium. Timepoint: During surgery. Method of measurement: Mg, syringe.
- Secondary Outcome Measures
Name Time Method eed for antagonism. Timepoint: During surgery and after surgery. Method of measurement: Mg, syringe.